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Abstract. A seroepidemiological study was performed to determine the seroprevalence of Cryptosporidium in
human immunodeficiency virus (HIV)-infected adults and local university students in the Limpopo Province, South
Africa. Using a custom anti-C. parvum immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA), the
seroprevalence of Cryptosporidium was found to be significantly higher (75.3%; 146 of 193) in HIV-infected individuals
compared with student volunteers (32.8%; 19 of 58) (P < 0.001). A more recent diagnosis of HIV was associated with
anti-C. parvum IgG seropositivity, as was lower weight among HIV-infected women. This is the first seroepidemiologic
study of Cryptosporidium in rural South Africa, and it shows high endemicity among the HIV-infected population. In
addition to raising the possibility of significant Cryptosporidium-related morbidities, this finding reveals that in Limpopo
and perhaps in other low-income, rural populations, interrupting waterborne pathogen transmission will require strate-
gies effective against environmentally hardy parasites such as Cryptosporidium.
INTRODUCTION
Cryptosporidium is a well-known cause of waterborne diar-
rhea in low-income countries. Infection is particularly severe
in immunocompromised hosts, namely malnourished children
who suffer from repeat infections,1 persistent diarrhea,2
childhood stunting,3–5 and individuals living with advanced
human immunodeficiency virus (HIV)/acquired immunodefi-
ciency syndrome (AIDS) who manifest chronic and even
severe cholera-like diarrhea.6,7 In resource-limited settings,
co-infection with Cryptosporidium and other diarrheal patho-
gens in patients with HIV/AIDS increases morbidity and
mortality, despite the initiation of anti-retroviral therapy,
adequate serum anti-retroviral levels, and an appropriate
immunological response to therapy.8–10 The current therapeu-
tic options for Cryptosporidium infection are only marginally
effective, and for highly endemic regions, innovative technolo-
gies are needed. In a recent pilot study that introduced ceramic
water filters into the homes of people living with HIV in the
Limpopo province, we found reduced diarrheal events and
decreased stool prevalence of Cryptosporidium in the inter-
vention households11; we thus sought to better describe
Cryptosporidium exposure among this population.
The Limpopo province of northern South Africa (popula-
tion 5.4 million gross domestic product US$11,000) has a high
HIV endemicity and presumptively high Cryptosporidium
exposure. The majority of the region is rural, and water qual-
ity shows that although access to an upgraded basic water
supply in the region has improved, fecal coliform counts of
groundwater boreholes, particularly community boreholes
during the rainy season, exceed both the South Africa and
World Health Organization’s (WHO) benchmark limits.12,13
We have previously reported that the stool-shedding prev-
alence of Cryptosporidium shedding by polymerase chain
reaction (PCR) in Limpopo is 13% among HIV-infected
adults hospitalized with chronic diarrhea (25.5% of among
all hospitalized patients). Whereas others had reported
Cryptosporidium-positive stools were present in 73.6% of chil-
dren in Uganda, only 17.9% of school children in the Vhembe
District were PCR-positive for Cryptosporidium.14–16 We also
found that 50% of those hospitalized, 50–59 years of age in
Limpopo, had stool PCR positive for Cryptosporidium. Thus,
it appeared that Cryptosporidium exposure was present in all
age groups, and although highly specific for incident infection,
the cross-sectional stool analysis may have underestimated
exposure possibly caused by temporal and seasonal variations
in Cryptosporidium transmission.17 To explore this possibility,
we performed a serological survey using an easy-to-perform
custom anti-Cryptosporidium immunoglobulinG (IgG) enzyme-
linked immunosorbent assay (ELISA) to enhance knowledge
of Cryptosporidium exposure in Limpopo.18,19
We assayed banked plasma samples (stored at −70°) from
194 serologically HIV-seropositive adults who presented at
seven provincial health care facilities (including both high
population density semi-urban communities: Bela Bela,
Polokwane, and Thohoyandou, and low density population
rural communities: Madimbo, Makulleke, Nithaveni, and
Mititti) in Limpopo Province, South Africa in 2007, and 58
fresh plasma samples (recovered from whole blood centri-
fuged at 2,000 rpm for 10 minutes within 4 hours of collection)
from student volunteers collected in August 2008.
To detect anti-Cryptosporidium IgG in serum, we used our
previously published custom ELISA that had a reported
sensitivity of 94% compared with stool microscopy using the
previously validated cutoff of (ODsample/ODnegative control) ³
1.820 (expressed as “ELISA units” [EU]). Cryptosporidium
parasite extract (PE) was prepared from a stock of 1 + 109
purified C. parvum oocysts (Iowa isolate; Waterborne, Inc.,
New Orleans, LA). Washed oocysts were resuspended in car-
bonate buffer (pH 9.6) and disrupted using a Branson sonifier
cell disrupter (model W140D; Heat System-Ultrasonics, Inc.,
Plainview, NY) until > 90% oocyst disruption was confirmed
by examination with a hemocytometer. The resulting PE was
coated onto 96-well plates at a final concentration of 0.2 mg/
100 mL/well and incubated in carbonate-bicarbonate coating
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buffer overnight at 4°C. Plates were washed three times with
wash solution (Kirkegaard & Perry Laboratories, Inc. [KPL,
Inc., Gaithersburg, MD]) to remove any uncoated proteins,
and wells were then blocked overnight with 1% phosphate
buffered saline-bovine serum albumin at 4°C(KPL, Inc.) and
washed before addition of 50 mL of plasma (1:32 dilution).
Following a 1-hour incubation at 37°C, the patient plasma
sample was washed, and 50 mL of alkaline phosphatase-conju-
gated goat anti-human IgG antibody (1:1,000) (KPL, Inc.),
was added and incubated at 37°C for another 1 hour. Follow-
ing repeat washing, p-nitrophenylphosphate substrate (Sigma
-Aldrich Diagnostics, St. Louis, MO) was added for the final
reaction step.20 Absorbance was read at 405 nm on a spec-
trophotometer beginning 5 minutes after addition of the
substrate and at 3–5-minute intervals thereafter for up to
60 minutes. Statistical analyses were performed using c2 and
Mann-Whitney t-test when applicable on IBM SPSS Statistics
v. 20 (IBM Corp., Armonk, NY) or GraphPad Prism 5.0 d
(GraphPad Software, Inc., La Jolla, CA) for Mac OSX. Miss-
ing data were categorized as “unknown” for each respective
variable. A P < 0.05 was considered statistically significant.
The optical density of internal negative and positive controls
ranged from 0.135–0.256 (mean ± SD; 0.1939 ± 0.039 for all
plates) and 0.5375–0.9061 (mean ± SD = 0.7826 ± 0.2050 for
all plates), respectively. Under varying laboratory conditions
(including humidity and temperature) there was 4–50%
variability among 18 samples repeated on separate days
(Student’s paired t test, P = 0.0683).
Among patients in the HIV-clinic cohort, the median
normalized Elisa Units (EU) values (EU-1.8) (range =
−1.006 to 4.566; median ± interquartile range (IQR) = 0.4591 ±
1.159; N = 194; 75.3% positive) were greater than EU values
among the student cohort (range = −1.190 to 1.228; median ±
IQR = −0.1571 ± 0.7517; N = 58; 32.8% positive) (P < 0.0001)
(Figure 1A). The student cohort was significantly younger
than the HIV-clinic cohort (median ± IQR = 22.0 ± 3 versus
34.50 ± 14, respectively, P < 0.05 Mann-Whitney). Within an
age-matched subgroup 35.7% (N = 42) of the student cohort
and 94.4% of HIV-clinic cohort (N = 18) were positive (P <
0.0001) (Figure 1B). Anti-C. parvum IgG seropositivity in the
Vhembe district ranged from 58% in communities in the
immediate vicinity of Thohoyandou to 80–100% in small rural
clinics in northern Vhembe (ns). The Polokwane and Bela-
Bela vicinity showed similar seropositivity, 70.0% and 64.4%,
respectively (ns) (Supplemental Figure 1). The widespread
and nearly universal exposure to Cryptosporidium among
those living with HIV in Limpopo is strikingly greater than
we had previously reported using stool diagnostics.14,15 The
findings raise important concerns regarding the high exposure
to waterborne pathogen exposure in this HIV-positive popu-
lation. Although this report does not enable us to infer demo-
graphic differences that account for the higher exposure in the
HIV-positive cohort compared with the student cohort, our
observation underlines the need for carefully designed future
case-control analyses that may identify particular associations
or behaviors that influence exposure to Cryptosporidium or
other waterborne pathogens in the region.
We performed a hypothesis-generating preliminary univar-
iate analysis on the HIV-clinic cohort subjects to evaluate
potential exposure risks (Table 1). Anti-C. parvum IgG sero-
positive subjects were more likely to have received a diagno-
sis of HIV within 6 years of sample collection (78.1%,),
whereas 58.4% of anti-C. parvum IgG seronegative subjects
were diagnosed with HIV 7 or more years prior (P = 0.040).
There was no significant difference in anti-C. parvum IgG
serostatus among patients with more advanced WHO Stage
disease (P = 0.204). Of those reporting a monthly income, the
highest proportion of anti-C. parvum IgG seropositive results
were in those receiving < 10,000 R/month or on subsidized
income, 76% (118 of 154); however, the prevalence of anti-C.
Figure 1. Anti-Cryptosporidium parvum immunoglobulin G
(IgG) antibody responses to C. parvum parasite extract among uni-
versity student and human immunodeficiency virus (HIV)-clinic
cohorts. (A) Normalized anti-C. parvum IgG enzyme-linked immu-
nosorbent assay (ELISA) Units (EU-1.8) such that values > zero are
seropositive. Among university students, 32.8% (N = 58) were posi-
tive (median ± interquartile range [IQR] = −0.1571 ± 0.7517) and
75.3% (N = 194) patients from HIV clinics were positive (median ±
IQR = 0.4591 ± 1.159) (P < 0.0001, Mann-Whitney). (B) Within an
age-matched sub-cohort of the two groups, 35.7% (N = 42) of univer-
sity students and 94.4% (N = 18) of HIV-clinic patients were positive
(P < 0.0001, c2).
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parvum IgG seropositivity was not statistically significant
across incomebrackets (P= 0.803).Although only preliminary,
this analysis conveys important information for local providers.
Cryptosporidium exposure is common across the spectrum
of HIV stages of disease (i.e., not just those with advanced
disease). Recent diagnosis of HIV can be interpreted as a sur-
rogate for access to health care and may represent a critical
opportunity to evaluate and educate regarding safe water-
sanitation practices among this population. Finally, patients
in all income brackets in this population have evidence of
exposure to Cryptosporidium. Given the known high coliform
counts in the community ground water in Limpopo21 this
additional information that highlights the high prevalence of
protozoal pathogens is critical to the design of local public
health interventions that emphasize point-of-use water purifi-
cation strategies and sanitation improvements that strive to
limit acquisition of waterborne pathogens both in Limpopo
and elsewhere.
In conclusion, we have used a simple and low-cost custom
ELISA to better define Cryptosporidium exposure in the
Limpopo Province of South Africa. We report that exposure
is highly endemic among HIV-co-infected individuals in the
region. Although more comprehensive studies are needed to
clarify specific risk factors and disease-associated morbidities
in this population, our observations emphasize an example of
the importance of establishing baseline knowledge of the
exposure to pathogens such as Cryptosporidium in popu-
lations who need improved water–sanitation technologies.
Knowledge of the high exposure to Cryptosporidium infection
in this population informs clinical decision making, the devel-
opment of public health strategies that are inclusive of tech-
nology that interrupts Cryptosporidium transmission, and
future investigations to gauge the effectiveness and sustain-
ability of water–sanitation interventions.
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Table 1
Univariate analysis of the human immunodeficiency virus (HIV)-clinic cohort by anti-C. parvum serostatus*
Characteristic
Seronegative (N = 48),
N (%)
Seropositive (N = 146),
N (%)
Total (N = 194),
N (%) P value (c2)
Age 0.074
< 25 years 6 (12.5) 30 (20.5) 36 (18.6)
26–35 years 15 (31.3) 52 (35.6) 67 (34.5)
36–45 years 18 (37.5) 34 (23.3) 52 (26.8)
> 45 years 3 (6.25) 24 (16.4) 27 (13.9)
NR† 6 (12.5) 6 (4.1) 12 (6.2)
Sex 0.683
Male 10 (20.8) 28 (19.2) 38 (19.6)
Female 34 (70.8) 112 (76.7) 146 (75.2)
NR† 4 (8.3) 6 (4.1) 10 (5.2)
Duration of HIV 0.040
1–3 years 13 (27.1) 58 (39.7) 71 (36.6)
4–6 years 15 (31.3) 56 (38.4) 71 (36.6)
7–10 years 13 (27.1) 17 (11.6) 30 (15.4)
> 10 years 3 (6.3) 2 (1.4) 5 (2.6)
NR† 4 (8.3) 13 (8.9) 17 (8.8)
WHO HIV/AIDS stage 0.204
Asymptomatic/primary HIV 0 (0.0) 5 (3.4) 5 (2.6)
I 8 (16.7) 36 (24.7) 44 (22.7)
II 10 (20.8) 25 (17.1) 35 (18.0)
III 13 (27.1) 32 (21.9) 45 (23.2)
IV 5 (10.4) 6 (4.1) 11 (5.7)
NR† 12 (25) 42 (28.8) 54 (27.8)
Monthly income 0.803
None 10 (20.8) 28 (19.2) 38 (19.6)
Agricultural 2 (4.2) 7 (4.8) 9 (4.6)
Subsidized grant 9 (18.8) 21 (43.8) 30 (15.4)
< 1,000 Rand (R)‡ 12 (41.7) 48 (32.9) 60 (30.9)
1,000–10,000 R 3 (6.3) 14 (9.6) 17 (8.8)
> 10,000 R 3 (6.3) 3 (2.1) 6 (3.1)
Unknown, used 1 (2.1) 3 (2.1) 4 (2.1)
Unknown, unemployed 1 (2.1) 3 (2.1) 4 (2.1)
NR† 7 (14.6) 21 (43.8) 26 (13.4)
Weight quartile M (10) F (31) M (27) F (97) M (37) F (128) < 0.001 (F)
< 53 kg 1 (10.0) 5 (16.1) 5 (18.5) 28 (28.9) 6 (16.2) 33 (25.8)
53–59 kg 3 (30.0) 5 (16.1) 7 (25.9) 24 (24.7) 10 (27.0) 29 (22.7)
60–66 kg 4 (40.0) 10 (32.3) 7 (25.9) 25 (25.8) 11 (29.7) 35 (27.3)
> 67 kg 2 (20.0) 11(35.5) 8 (29.6) 20 (20.1) 10 (27.0) 31 (24.2)
*“Seropositive” and “Seronegative” refer to anti-Cryptosporidium parvum immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) result. Data are stratified into quartiles
where appropriate and P values determined by c2. M = male, F = female.
†NR = no response.
‡1,000 Rand ≊120 US$.
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